Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir
Author(s) -
Donald M. Coen,
D. Goldstein,
Sandra K. Weller
Publication year - 1989
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.33.8.1395
Subject(s) - ribonucleotide reductase , herpes simplex virus , mutant , aphidicolin , virology , virus , biology , aciclovir , simplexvirus , herpesviridae , enzyme , biochemistry , viral disease , dna polymerase , gene , protein subunit
Two mutants defective in herpes simplex virus-encoded ribonucleotide reductase activity exhibited the novel phenotype of hypersensitivity to acyclovir, aphidicolin, and to a lesser extent, phosphonoacetic acid. These results have implications for acyclovir resistance and the development of drugs that potentiate acyclovir action by inhibition of viral ribonucleotide reductase.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom